Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cells
- 22 May 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 224 (2) , 509-515
Abstract
The potential of mesenchymal stem cells (MSC) to differentiate into functional bone forming cells provides an important tool for bone regeneration. The identification of factors capable of promoting osteoblast differentiation in MSCs is therefore critical to enhance the osteogenic potential of MSCs. Using microarray analysis combined with biochemical and molecular approach, we found that FGF18, a member of the FGF family, is upregulated during osteoblast differentiation induced by dexamethasone in murine MSCs. We showed that overexpression of FGF18 by lentiviral (LV) infection, or treatment of MSCs with recombinant human (rh)FGF18 increased the expression of the osteoblast specific transcription factor Runx2, and enhanced osteoblast phenotypic marker gene expression and in vitro osteogenesis. Molecular silencing using lentiviral shRNA demonstrated that downregulation of FGFR1 or FGFR2 abrogated osteoblast gene expression induced by either LV‐FGF18 or rhFGF18, indicating that FGF18 enhances osteoblast differentiation in MSCs via activation of FGFR1 or FGFR2 signaling. Biochemical and pharmacological analyses showed that the induction of phenotypic osteoblast markers by LV‐FGF18 is mediated by activation of ERK1/2‐MAPKs and PI3K signaling in MSCs. These results reveal that FGF18 is an essential autocrine positive regulator of the osteogenic differentiation program in murine MSCs and indicate that osteogenic differentiation induced by FGF18 in MSCs is triggered by FGFR1/FGFR2‐mediated ERK1/2‐MAPKs and PI3K signaling. J. Cell. Physiol. 224: 509–515, 2010.Keywords
This publication has 42 references indexed in Scilit:
- Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma‐derived mesenchymal stem cellsJournal of Cellular Biochemistry, 2007
- Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal developmentJournal of Cell Biology, 2007
- Direct Interactions of Runx2 and Canonical Wnt Signaling Induce FGF18Journal of Biological Chemistry, 2007
- Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondriumGenes & Development, 2006
- Stem CellsAnnals of the New York Academy of Sciences, 2006
- Mechanisms underlying differential responses to FGF signalingCytokine & Growth Factor Reviews, 2005
- Gene Expression Changes in the Course of Neural Progenitor Cell DifferentiationThe Journal of Neuroscience, 2004
- Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in OsteoblastsJournal of Biological Chemistry, 2004
- Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML FactorsCritical Reviews™ in Eukaryotic Gene Expression, 2004
- Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte MaturationJournal of Bone and Mineral Research, 1999